Clinical Trial Update: Comparison of Two Heparin Formulations in Patients With Chronic Renal Failure. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing two heparin formulations in patients with chronic kidney disease to evaluate thrombus-related outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Thrombosis

Drugs mentioned

• Heparin formulation A (unfractionated heparin)
• Heparin formulation B (low molecular weight heparin)

Snippet

Sponsor: Azidus Brasil | Conditions: Thrombus | Phase 3 | Status: UNKNOWN